Skip to main content
. 2022 Apr 16;47:101384. doi: 10.1016/j.eclinm.2022.101384

Table 4.

Multivariable analyses investigating the association between lung cancer and elevated peak intensities of volatile organic compounds (VOCs).

Elevated VOCs Lung cancers vs. Healthy individuals
Ad-OR (95% CI) P values
Acetaldehyde 1.79 (1.20–2.66) 0.002
2-Hydroxyacetaldehyde 1.99 (1.35–2.92) <0.001
Isoprene 20.5 (12.6–33.3) <0.001
Pentanal 8.55 (5.60–13.0) <0.001
Butyric acid 2.06 (1.38–3.07) <0.001
Toluene 8.24 (5.12–13.3) <0.001
2,5-Dimethylfuran 8.15 (5.07–13.1) <0.001
Cyclohexanone 2.86 (1.94–4.22) <0.001
Hexanal 20.8 (12.4–35.1) <0.001
Heptanal 5.07 (3.32–7.73) <0.001
Acetophenone 5.05 (3.24–7.86) <0.001
Propylcyclohexane 7.31 (4.77–11.2) <0.001
Octanal 3.64 (2.40–5.51) <0.001
Nonanal 8.63 (5.64–13.2) <0.001
Decanal 4.45 (2.98–6.63) <0.001
2,2-Dimethyldecane 7.17 (4.74–10.8) <0.001

Adjusted confounding factors: age, gender, smoking history, alcohol history, diabetes, and cardiovascular diseases.

Multivariate logistic regression models with the backward conditional methods were used.

Elevated VOC was defined as peak intensity over the up tertiles.

Ad-OR: adjusted odds ratio; CI: confidence interval.